Compounders Research Compare

Estrella Immunopharma, Inc.(ESLA)

Biotechnology · EmeryVille, CA

$0.43-0.01 (-2.50%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Estrella Immunopharma, Inc.

Estrella Immunopharma, Inc. is an early-stage biopharmaceutical enterprise focused on creating T-cell therapies for various blood cancers and solid tumors, with its primary activities centered in the United States. The company's lead investigational drugs include EB103, which is in preclinical development for diffuse large B-cell lymphoma, and EB104, intended for the treatment of both diffuse large B-cell lymphoma and acute lymphocytic leukemia. Estrella also maintains a collaborative agreement with Imugene Limited, working together to develop solid tumor therapies that integrate Imugene's CF33-CD19t product candidate with Estrella's EB103. The company is based in Emeryville, California.

EmeryVille, CA

3 employees

www.estrellabio.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Cheng Liu

View full financials

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T21:41:29.138Z.

Stored calculation inputs

Calculation as of: 2026-10-06T21:41:29.138Z.

Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-06-30: -0.2462
Quote price: 0.429

FMP input reference: 2d15fccd73dd71321fa30efb235d10704747171fee005d1a5dd6499fafc6c703

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

ESLA Earnings Yield Metrics

EARNINGS YIELD

N/A

ESLA Competitors' Earnings Yield

Estrella Immunopharma, Inc.

Current

Market Cap

$18.30M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

P3 Health Partners Inc.

Market Cap

$18.41M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Neuphoria Therapeutics Inc.

Market Cap

$18.65M

Earnings Yield

N/A

TTM Avg

66.69%

3Y Avg

66.69%

5Y Avg

66.69%

Cosmos Health Inc.

Market Cap

$17.39M

Earnings Yield

N/A

TTM Avg

2.31%

3Y Avg

2.31%

5Y Avg

2.31%

Lipocine Inc.

Market Cap

$17.31M

Earnings Yield

N/A

TTM Avg

0.00%

3Y Avg

5.85%

5Y Avg

5.85%

Actuate Therapeutics Inc

Market Cap

$19.42M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PAVmed Inc.

Market Cap

$17.07M

Earnings Yield

N/A

TTM Avg

194.82%

3Y Avg

194.82%

5Y Avg

194.82%

Marker Therapeutics, Inc.

Market Cap

$16.84M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Quantum BioPharma Ltd.

Market Cap

$19.77M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TScan Therapeutics, Inc.

Market Cap

$16.82M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Estrella Immunopharma, Inc. (ESLA)	$18.30M	N/A	N/A	N/A	N/A
P3 Health Partners Inc. (PIII)vs ›	$18.41M	N/A	N/A	N/A	N/A
Neuphoria Therapeutics Inc. (NEUP)vs ›	$18.65M	N/A	66.69%	66.69%	66.69%
Cosmos Health Inc. (COSM)vs ›	$17.39M	N/A	2.31%	2.31%	2.31%
Lipocine Inc. (LPCN)vs ›	$17.31M	N/A	0.00%	5.85%	5.85%
Actuate Therapeutics Inc (ACTU)vs ›	$19.42M	N/A	N/A	N/A	N/A
PAVmed Inc. (PAVM)vs ›	$17.07M	N/A	194.82%	194.82%	194.82%
Marker Therapeutics, Inc. (MRKR)vs ›	$16.84M	N/A	N/A	N/A	N/A
Quantum BioPharma Ltd. (QNTM)vs ›	$19.77M	N/A	N/A	N/A	N/A
TScan Therapeutics, Inc. (TCRX)vs ›	$16.82M	N/A	N/A	N/A	N/A

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

P/E Ratio FCF Yield Dividend Yield All Metrics